BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30536524)

  • 1. The role of Eomes in human CD4 T cell differentiation: A question of context.
    Dejean AS; Joulia E; Walzer T
    Eur J Immunol; 2019 Jan; 49(1):38-41. PubMed ID: 30536524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
    Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
    Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
    Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
    J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation.
    Mazzoni A; Maggi L; Siracusa F; Ramazzotti M; Rossi MC; Santarlasci V; Montaini G; Capone M; Rossettini B; De Palma R; Kruglov A; Chang HD; Cimaz R; Maggi E; Romagnani S; Liotta F; Cosmi L; Annunziato F
    Eur J Immunol; 2019 Jan; 49(1):79-95. PubMed ID: 30144030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eomes expression reports the progressive differentiation of IFN-γ-producing Th1-like γδ T cells.
    Lino CNR; Barros-Martins J; Oberdörfer L; Walzer T; Prinz I
    Eur J Immunol; 2017 Jun; 47(6):970-981. PubMed ID: 28386934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4
    Thelen B; Schipperges V; Knörlein P; Hummel JF; Arnold F; Kupferschmid L; Klose CSN; Arnold SJ; Boerries M; Tanriver Y
    Front Immunol; 2023; 14():1058267. PubMed ID: 36756120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4
    Roessner PM; Llaó Cid L; Lupar E; Roider T; Bordas M; Schifflers C; Arseni L; Gaupel AC; Kilpert F; Krötschel M; Arnold SJ; Sellner L; Colomer D; Stilgenbauer S; Dietrich S; Lichter P; Izcue A; Seiffert M
    Leukemia; 2021 Aug; 35(8):2311-2324. PubMed ID: 33526861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
    Stienne C; Michieletto MF; Benamar M; Carrié N; Bernard I; Nguyen XH; Lippi Y; Duguet F; Liblau RS; Hedrick SM; Saoudi A; Dejean AS
    Immunity; 2016 Oct; 45(4):774-787. PubMed ID: 27742544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression.
    Suto A; Wurster AL; Reiner SL; Grusby MJ
    J Immunol; 2006 Sep; 177(6):3721-7. PubMed ID: 16951332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of transcription factor T-bet and Eomes in IFN-gamma secretion of different human T cell subsets].
    Wang HT; Ge XS; Xue ZP; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):31-4. PubMed ID: 20056084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
    Mittal P; Abblett R; Ryan JM; Hagymasi AT; Agyekum-Yamoah A; Svedova J; Reiner SL; St Rose MC; Hanley MP; Vella AT; Adler AJ
    J Immunol; 2018 Feb; 200(4):1513-1526. PubMed ID: 29305435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human CD4
    Pulvirenti N; Silvetri Y; Clemente F; Bosotti R; Carelli E; Moschetti G; Gruarin P; Vasco C; Crosti MC; Sarnicola ML; Valenti L; Prati D; Abrignani S; Geginat J
    Eur J Immunol; 2024 Apr; 54(4):e2350675. PubMed ID: 38396108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.
    Eshima K; Chiba S; Suzuki H; Kokubo K; Kobayashi H; Iizuka M; Iwabuchi K; Shinohara N
    Immunol Lett; 2012 May; 144(1-2):7-15. PubMed ID: 22425747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
    Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
    J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schisandrin B inhibits Th1/Th17 differentiation and promotes regulatory T cell expansion in mouse lymphocytes.
    Chen Z; Guo M; Song G; Gao J; Zhang Y; Jing Z; Liu T; Dong C
    Int Immunopharmacol; 2016 Jun; 35():257-264. PubMed ID: 27085037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway.
    Yokosawa M; Kondo Y; Tahara M; Iizuka-Koga M; Segawa S; Kaneko S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T
    Clin Exp Immunol; 2017 Apr; 188(1):22-35. PubMed ID: 27936495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
    Hassouneh F; Lopez-Sejas N; Campos C; Sanchez-Correa B; Tarazona R; Pera A; Solana R
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gfi1, a transcriptional repressor, inhibits the induction of the T helper type 1 programme in activated CD4 T cells.
    Suzuki J; Maruyama S; Tamauchi H; Kuwahara M; Horiuchi M; Mizuki M; Ochi M; Sawasaki T; Zhu J; Yasukawa M; Yamashita M
    Immunology; 2016 Apr; 147(4):476-87. PubMed ID: 26749286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
    Takeuchi A; Badr Mel S; Miyauchi K; Ishihara C; Onishi R; Guo Z; Sasaki Y; Ike H; Takumi A; Tsuji NM; Murakami Y; Katakai T; Kubo M; Saito T
    J Exp Med; 2016 Jan; 213(1):123-38. PubMed ID: 26694968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.
    Pikovskaya O; Chaix J; Rothman NJ; Collins A; Chen YH; Scipioni AM; Vivier E; Reiner SL
    J Immunol; 2016 Feb; 196(4):1449-54. PubMed ID: 26792802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.